HUP0402570A3 - Prophylactic and therapeutic treatment of infectious and other diseases with aminoalkyl glucosaminide phosphate (cyclic a 6p) immunoeffector compounds - Google Patents
Prophylactic and therapeutic treatment of infectious and other diseases with aminoalkyl glucosaminide phosphate (cyclic a 6p) immunoeffector compoundsInfo
- Publication number
- HUP0402570A3 HUP0402570A3 HU0402570A HUP0402570A HUP0402570A3 HU P0402570 A3 HUP0402570 A3 HU P0402570A3 HU 0402570 A HU0402570 A HU 0402570A HU P0402570 A HUP0402570 A HU P0402570A HU P0402570 A3 HUP0402570 A3 HU P0402570A3
- Authority
- HU
- Hungary
- Prior art keywords
- prophylactic
- infectious
- diseases
- cyclic
- therapeutic treatment
- Prior art date
Links
- 229910019142 PO4 Inorganic materials 0.000 title 1
- 125000004103 aminoalkyl group Chemical group 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 125000004122 cyclic group Chemical group 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 150000008271 glucosaminides Chemical class 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 230000002458 infectious effect Effects 0.000 title 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 title 1
- 239000010452 phosphate Substances 0.000 title 1
- 230000000069 prophylactic effect Effects 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
- A61K47/544—Phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2002/003581 WO2003066065A1 (en) | 2002-02-04 | 2002-02-04 | Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0402570A2 HUP0402570A2 (hu) | 2005-10-28 |
| HUP0402570A3 true HUP0402570A3 (en) | 2006-02-28 |
Family
ID=27732076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0402570A HUP0402570A3 (en) | 2002-02-04 | 2002-02-04 | Prophylactic and therapeutic treatment of infectious and other diseases with aminoalkyl glucosaminide phosphate (cyclic a 6p) immunoeffector compounds |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1482955B1 (hu) |
| JP (1) | JP2005523902A (hu) |
| KR (1) | KR100858947B1 (hu) |
| CN (2) | CN1622812A (hu) |
| AU (1) | AU2002255513B2 (hu) |
| BR (1) | BR0215583A (hu) |
| CA (1) | CA2474402C (hu) |
| CZ (1) | CZ2004861A3 (hu) |
| ES (1) | ES2453903T3 (hu) |
| HU (1) | HUP0402570A3 (hu) |
| IL (1) | IL163305A (hu) |
| MX (1) | MXPA04007491A (hu) |
| NO (1) | NO20043693L (hu) |
| NZ (1) | NZ534592A (hu) |
| WO (1) | WO2003066065A1 (hu) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6911434B2 (en) | 2002-02-04 | 2005-06-28 | Corixa Corporation | Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds |
| KR100885008B1 (ko) * | 2002-02-04 | 2009-02-20 | 코릭사 코포레이션 | 신규 면역효과기 화합물 |
| JP5099343B2 (ja) * | 2005-03-04 | 2012-12-19 | 独立行政法人理化学研究所 | 環状構造を有する化合物及びその用途 |
| US8722064B2 (en) | 2009-06-05 | 2014-05-13 | Infectious Disease Research Institute | Synthetic glucopyranosyl lipid adjuvants |
| GB201101331D0 (en) | 2011-01-26 | 2011-03-09 | Glaxosmithkline Biolog Sa | Compositions and uses |
| GB201113570D0 (en) | 2011-08-05 | 2011-09-21 | Glaxosmithkline Biolog Sa | Vaccine |
| US20220273789A1 (en) | 2019-07-21 | 2022-09-01 | Glaxosmithkline Biologicals Sa | Therapeutic viral vaccine |
| WO2021245611A1 (en) | 2020-06-05 | 2021-12-09 | Glaxosmithkline Biologicals Sa | Modified betacoronavirus spike proteins |
| EP4032547A1 (en) | 2021-01-20 | 2022-07-27 | GlaxoSmithKline Biologicals S.A. | Hsv1 fce derived fragements for the treatment of hsv |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
| JP5004261B2 (ja) | 2000-05-19 | 2012-08-22 | コリクサ コーポレイション | 単糖類及び二糖類に基づく化合物を用いた感染症及び他の疾患の予防的並びに治療的な処置 |
| AU8100101A (en) | 2000-08-04 | 2002-02-18 | Corixa Corp | New immunoeffector compounds |
| KR100885008B1 (ko) * | 2002-02-04 | 2009-02-20 | 코릭사 코포레이션 | 신규 면역효과기 화합물 |
-
2002
- 2002-02-04 EP EP02724914.3A patent/EP1482955B1/en not_active Expired - Lifetime
- 2002-02-04 CZ CZ2004861A patent/CZ2004861A3/cs unknown
- 2002-02-04 CN CNA028284356A patent/CN1622812A/zh active Pending
- 2002-02-04 BR BR0215583-4A patent/BR0215583A/pt not_active Application Discontinuation
- 2002-02-04 CN CN200710161297XA patent/CN101138566B/zh not_active Expired - Lifetime
- 2002-02-04 IL IL16330502A patent/IL163305A/xx unknown
- 2002-02-04 KR KR1020047011969A patent/KR100858947B1/ko active IP Right Grant
- 2002-02-04 CA CA2474402A patent/CA2474402C/en not_active Expired - Lifetime
- 2002-02-04 ES ES02724914.3T patent/ES2453903T3/es not_active Expired - Lifetime
- 2002-02-04 HU HU0402570A patent/HUP0402570A3/hu unknown
- 2002-02-04 MX MXPA04007491A patent/MXPA04007491A/es active IP Right Grant
- 2002-02-04 WO PCT/US2002/003581 patent/WO2003066065A1/en active Application Filing
- 2002-02-04 JP JP2003565489A patent/JP2005523902A/ja not_active Withdrawn
- 2002-02-04 NZ NZ534592A patent/NZ534592A/en not_active IP Right Cessation
- 2002-02-04 AU AU2002255513A patent/AU2002255513B2/en not_active Expired
-
2004
- 2004-09-03 NO NO20043693A patent/NO20043693L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1482955A4 (en) | 2008-08-06 |
| ES2453903T3 (es) | 2014-04-08 |
| EP1482955A1 (en) | 2004-12-08 |
| CN101138566A (zh) | 2008-03-12 |
| MXPA04007491A (es) | 2004-11-10 |
| JP2005523902A (ja) | 2005-08-11 |
| WO2003066065A1 (en) | 2003-08-14 |
| BR0215583A (pt) | 2004-12-21 |
| CA2474402C (en) | 2012-09-11 |
| NO20043693L (no) | 2004-09-03 |
| CA2474402A1 (en) | 2003-08-14 |
| KR20040081174A (ko) | 2004-09-20 |
| HUP0402570A2 (hu) | 2005-10-28 |
| EP1482955B1 (en) | 2013-12-25 |
| CZ2004861A3 (cs) | 2004-12-15 |
| AU2002255513B2 (en) | 2008-03-06 |
| CN1622812A (zh) | 2005-06-01 |
| KR100858947B1 (ko) | 2008-09-17 |
| CN101138566B (zh) | 2012-05-23 |
| AU2002255513A1 (en) | 2003-09-02 |
| NZ534592A (en) | 2006-06-30 |
| IL163305A (en) | 2010-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003203008A8 (en) | Method of manufacture medical devices employing microwave energy | |
| AU2002366355A1 (en) | SEQUESTRATION OF ABeta IN THE PERIPHERY IN THE ABSENCE OF IMMUNOMODULATING AGENT AS A THERAPEUTIC APPROACH FOR THE TREATMENT OR PREVENTION OF BETA-AMYLOID RELATED DISEASES | |
| IL186495A0 (en) | Use of disaccharide-based compounds for the manufacture of medicaments for prophylactic and therapeutic treatment of infectious and other diseases | |
| AU2003301256A1 (en) | Timed delay for redelivery of treatment therapy for a medical device system | |
| EG26417A (en) | A method for preparing collagen sponges has improved physical properties to heal and block wounds | |
| AU2002368274A8 (en) | Methods of treating infection by drug resistant bacteria | |
| GB0020351D0 (en) | Treatment of hyperproliferative diseases | |
| AU7434101A (en) | Treatment of bone diseases | |
| EP1385543A4 (en) | HUMAN MEDICAL TREATMENT BY IMMUNOGLOBULIN A APPLICATION | |
| HUP0402570A3 (en) | Prophylactic and therapeutic treatment of infectious and other diseases with aminoalkyl glucosaminide phosphate (cyclic a 6p) immunoeffector compounds | |
| AU1167602A (en) | Methods of therapy for hiv infection | |
| EP1525216A4 (en) | COMBINATION THERAPY FOR THE TREATMENT OF HIV INFECTION | |
| AU2002310403A1 (en) | Radioactive medical devices and methods of making radioactive medical devices | |
| PL368718A1 (en) | Method for treating hepatitis c virus infection in treatment failure patients | |
| AU2001251526A1 (en) | Method of inactivating pathogens | |
| IL160882A0 (en) | Method for treating hepatitis c virus infection in treatment failure patients | |
| AU2001263828A1 (en) | Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof | |
| PL371248A1 (en) | Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds | |
| AU2002327531A1 (en) | Therapeutic compositions and methods for treating viral infection | |
| AU1324002A (en) | Treatment of demyelinating diseases | |
| AU3632899A (en) | Method for the therapeutic and prophylactic treatment of dental diseases | |
| GB0216098D0 (en) | Treatment of TSE infection | |
| EP1150939A4 (en) | NEPHRONINE: SERIES OF COMPOUNDS FOR THE TREATMENT OF INFECTIOUS DISEASES AND CANCER | |
| AU2002258458A1 (en) | Biotin-binding compounds for induction of sterility in plants | |
| AU2002240883A1 (en) | System and method for improving the medical treatment of a patient |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |